Cargando…

Fracture Risk in Trans Women and Trans Men Using Long‐Term Gender‐Affirming Hormonal Treatment: A Nationwide Cohort Study

Concerns about bone health in transgender people using gender‐affirming hormonal treatment (HT) exist, but the fracture risk is not known. In this nationwide cohort study, we aimed to compare the fracture incidence in transgender people using long‐term HT with an age‐matched reference population. Al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiepjes, Chantal M, de Blok, Christel JM, Staphorsius, Annemieke S, Nota, Nienke M, Vlot, Mariska C, de Jongh, Renate T, den Heijer, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003754/ https://www.ncbi.nlm.nih.gov/pubmed/31487065 http://dx.doi.org/10.1002/jbmr.3862

Ejemplares similares

Bone Safety During the First Ten Years of Gender‐Affirming Hormonal Treatment in Transwomen and Transmen
por: Wiepjes, Chantal M, et al.
Publicado: (2018)

Gender‐Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen
por: Vlot, Mariska C, et al.
Publicado: (2019)

Incidence of testicular cancer in trans women using gender‐affirming hormonal treatment: a nationwide cohort study
por: de Nie, Iris, et al.
Publicado: (2021)

Frequency and outcomes of benign breast biopsies in trans women: A nationwide cohort study
por: de Blok, Christel JM., et al.
Publicado: (2021)

Development of Hip Bone Geometry During Gender‐Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty
por: van der Loos, Maria ATC, et al.
Publicado: (2021)

The effect of transdermal gender-affirming hormone therapy on markers of inflammation and hemostasis
por: Schutte, Moya H., et al.
Publicado: (2022)

SAT416 The Incidence Of Autoimmune Disease In Transgender People After Initiation Of Gender-Affirming Hormone Therapy
por: Wiepjes, Chantal, et al.
Publicado: (2023)

Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment
por: de Nie, Iris, et al.
Publicado: (2020)

Progesterone in gender-affirming therapy of trans women
por: Milionis, Charalampos, et al.
Publicado: (2022)

Positive and Negative Affect Changes during Gender-Affirming Hormonal Treatment: Results from the European Network for the Investigation of Gender Incongruence (ENIGI)
por: Matthys, Imke, et al.
Publicado: (2021)

Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection
por: Vlot, Mariska C., et al.
Publicado: (2018)

Effect of gender‐affirming hormone use on coagulation profiles in transmen and transwomen
por: Scheres, Luuk J.J., et al.
Publicado: (2021)

Vaginal and reproductive organ preservation in trans men undergoing gender-affirming phalloplasty: technical considerations
por: Salgado, Christopher J, et al.
Publicado: (2021)

Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands
por: de Blok, Christel J M, et al.
Publicado: (2019)

Development of Hip Bone Geometry in Transgender Adolescents Resembles the Experienced Gender if GnRHa Treatment Is Started in Early, but Not Late, Puberty
por: van der Loos, Maria A T C, et al.
Publicado: (2021)

Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long Term Follow up Study on Prevalence, Determinants, and the Effect of Years of Exposure
por: Madsen, Milou Cecilia, et al.
Publicado: (2021)

OR31-06 Gender-Affirming Hormone Therapy Affects Serum Cystatin C-based eGFR In Transgender Individuals
por: van Eeghen, Sarah A, et al.
Publicado: (2023)

Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years
por: Madsen, Milou Cecilia, et al.
Publicado: (2021)

Trans* people’s access to gender-affirming health care: A European comparison
por: Breckenkamp, J, et al.
Publicado: (2022)

Change in grip strength in trans people and its association with lean body mass and bone density
por: Scharff, Miranda, et al.
Publicado: (2019)

SAT411 The Influence Of Gender Affirming Hormone Therapy On Markers Of Platelet Activation In Transgender Women
por: van Zijverden, L Mees, et al.
Publicado: (2023)

Response to Letter to the Editor From Laidlaw: “Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-term Follow-up Study on Prevalence, Determinants, and Exposure Years”
por: Madsen, Milou C, et al.
Publicado: (2021)

MON-195 Trans-transgender Female: Gender Identity Reversal Following Irreversible Gender Affirming Surgeries
por: Korpaisarn, Sira, et al.
Publicado: (2019)

OR31-01 The Dose-dependent Effect Of Estrogen On Bone Mineral Density In Trans Girls
por: Boogers, Lidewij S, et al.
Publicado: (2023)

Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study
por: Kuijpers, Suzanne M E, et al.
Publicado: (2021)

Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy
por: Klaver, Maartje, et al.
Publicado: (2021)

Incident Diabetes Risk Is Not Increased in Transgender Individuals Using Hormone Therapy
por: van Velzen, Daan, et al.
Publicado: (2021)

SUN-LB14 Trans and Non-Binary Youth Accessing Gender Affirming Medical Care in Canada: New Research From the Trans Youth CAN!
por: Mokashi, Arati, et al.
Publicado: (2020)

The experiences of gender diverse and trans children and youth considering and initiating medical interventions in Canadian gender-affirming speciality clinics
por: Pullen Sansfaçon, Annie, et al.
Publicado: (2019)

Trends in suicide death risk in transgender people: results from the Amsterdam Cohort of Gender Dysphoria study (1972–2017)
por: Wiepjes, C. M., et al.
Publicado: (2020)

Accessing and utilising gender-affirming healthcare in England and Wales: trans and non-binary people’s accounts of navigating gender identity clinics
por: Wright, Talen, et al.
Publicado: (2021)

Just as Tall on Testosterone; a Neutral to Positive Effect on Adult Height of GnRHa and Testosterone in Trans Boys
por: Willemsen, Lieve Anne, et al.
Publicado: (2022)

Developing Trans-Affirming Health Services in an Underserved Area: An Intersectional Approach
por: Loza, Oralia, et al.
Publicado: (2018)

Piloting a Genital Affirmation Surgical Priorities Scale for Trans Masculine Patients
por: Ganor, Oren, et al.
Publicado: (2019)

Mapping evidence on the effects of gender-affirming hormone therapy on the hard and soft tissues of the craniofacial complex in transgender people: a protocol for a scoping review
por: Van den Bosch, M. F., et al.
Publicado: (2021)

Reluctant educators and self‐advocates: Older trans adults’ experiences of health‐care services and practitioners in seeking gender‐affirming services
por: Willis, Paul, et al.
Publicado: (2020)

Short‐Term Glucocorticoid Treatment Reduces Circulating Sclerostin Concentrations in Healthy Young Men: A Randomized, Placebo‐Controlled, Double‐Blind Study
por: Jacobsson, Merel, et al.
Publicado: (2020)

Evaluation of an e-Learning Curriculum for Forensic Nurses on Trans-Affirming Postsexual Assault Care
por: Du Mont, Janice, et al.
Publicado: (2021)

tranSMART
por: Bierkens, Mariska, et al.
Publicado: (2015)

Living conditions, HIV and gender affirmation care pathways of transgender people living with HIV in France: a nationwide, comprehensive, cross-sectional, community-based research protocol (ANRS Trans&HIV)
por: Mora, Marion, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ubr6teik8uejijpgoal6js8uhf